Low Dose Molecular Breast Imaging for Breast Cancer Detection
Lead Participant:
KROMEK LIMITED
Abstract
Kromek are developing a Low Dose Molecular Breast Imaging Technology, which can solve the problem of the low sensitivity of mammography in dense breasts. The project, in collaboration with NUTH, Newcastle University and UCL, will continue the development and collect data critical to the adoption of the technology.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| KROMEK LIMITED | £1,223,446 | £ 734,068 |
Participant |
||
| INNOVATE UK | ||
| NEWCASTLE UNIVERSITY | £39,823 | £ 39,823 |
| NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST | ||
| UNIVERSITY COLLEGE LONDON | £229,793 | £ 229,793 |
| THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST | £451,852 | £ 451,852 |
People |
ORCID iD |
| Ian Baistow (Project Manager) |